$2.22
-0.11 (-4.72%)
DURECT Corp (DRRX)
CAPS Rating:
The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

RSS Headlines
Fool UK